Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Tandem Diabetes Care Q2 2024 GAAP EPS $(0.47) Beats $(0.53) Estimate, Sales $221.910M Beat $204.902M Estimate

Author: Benzinga Newsdesk | August 01, 2024 04:10pm
Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.53) by 11.32 percent. The company reported quarterly sales of $221.910 million which beat the analyst consensus estimate of $204.902 million by 8.30 percent. This is a 13.27 percent increase over sales of $195.917 million the same period last year.

Posted In: TNDM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist